申请人:Erik Rytter Ottosen
公开号:US20060128766A1
公开(公告)日:2006-06-15
The invention relates to novel compounds according to formula Ia and Ib,
said compounds being useful, e.g. in the treatment of inflammatory, ophthalmic diseases, or cancer.
该发明涉及根据式Ia和Ib的新化合物,这些化合物可用于治疗炎症性、眼科疾病或癌症等疾病。